Skip to main content
SpringerLink
Log in
Book cover

Uterine Cancer pp 3–11Cite as

Epidemiology of Endometrial Cancers and Uterine Sarcomas

  • Chapter

  • 1259 Accesses

Abstract

Globally, cancer of the body of the uterus, also known as corpus uteri cancer, is the sixth most common cancer among women. It has been estimated that in the year 2012, cancers of the corpus uteri accounted for 319,605 new cases. This accounted for 4.8 % of the total cancers among women with an age-standardized rate (ASR) of 8.3 per 100,000 women. There were an estimated 76,160 deaths due to endometrial cancers among women globally during 2012.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   149.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. GLOBOCAN 2012. v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr. Accessed 23 Dec 2014.

  2. American Cancer Society: Cancer Facts and Figures 2013. Atlanta: American Cancer Society; 2013. Available online. Last accessed 14 May 2013.

    Google Scholar 

  3. American Cancer Society Information. http://www.cancer.org/cancer/endometrialcancer/detailedguide/. Accessed 7 Jun 2015.

  4. Elwood JM, Cole P, Rothman KJ, Kaplan SD. Epidemiology of endometrial cancer. Br J Hosp Med. 1997;59:1055–60.

    Google Scholar 

  5. Brinton LA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Lannom L, Hoover RN. Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case–control study. Am J Obstet Gynecol. 1992;167:1317–25.

    Article  CAS  PubMed  Google Scholar 

  6. Reis N, Beji NK. Risk factors for endometrial cancer in Turkish women: results from a hospital-based case–control study. Eur J Oncol Nurs. 2009;13(2):122–7.

    Article  PubMed  Google Scholar 

  7. Dossus L, Allen N, Kaaks R, Bakken K, Lund E, Tjonneland A, Olsen A, Overvad K, Clavel-Chapelon F, Fournier A, Chabbert-Buffet N, Boeing H, Schütze M, Trichopoulou A, Trichopoulos D, Lagiou P, Palli D, Krogh V, Tumino R, Vineis P, Mattiello A, Bueno-de-Mesquita HB, Onland-Moret NC, Peeters PH, Dumeaux V, Redondo ML, Duell E, Sanchez-Cantalejo E, Arriola L, Chirlaque MD, Ardanaz E, Manjer J, Borgquist S, Lukanova A, Lundin E, Khaw KT, Wareham N, Key T, Chajes V, Rinaldi S, Slimani N, Mouw T, Gallo V, Riboli E. Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2010;127(2):442–51.

    CAS  PubMed  Google Scholar 

  8. Pettersson B, Adami HO, Bergstrom R, Johansson ED. Menstruation span as a time-limited risk factor for endometrial carcinoma. Acta Obstet Gynaecol Scand. 1986;65:247–55.

    Article  CAS  Google Scholar 

  9. Lambe M, Wuu J, Weiderpass E, Hsieh CC. Childbearing at older age and endometrial cancer risk (Sweden). Cancer Causes Control. 1999;10:43–9.

    Article  CAS  PubMed  Google Scholar 

  10. Parazzini F, La Vecchia C, Negri E, Fedele L, Balotta F. Reproductive factors and risk of endometrial cancer. Am J Obstet Gynecol. 1991;164:522–7.

    Article  CAS  PubMed  Google Scholar 

  11. Kvåle G, Heuch I, Ursin G. Reproductive factors and risk of cancer of the uterine corpus: a prospective study. Cancer Res. 1988;48(21):6217–21.

    PubMed  Google Scholar 

  12. Jafari K, Javaheri G, Ruiz G. Endometrial adenocarcinoma and the Stein-Leventhal syndrome. Obstet Gynecol. 1978;51:97–100.

    CAS  PubMed  Google Scholar 

  13. Maxwell GL, Schildkraut JM, Calingaert B, Risinger JI, Dainty L, Marchbanks PA, Berchuck A, Barrett JC, Rodriguez GC. Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk (CASH-study). Gynecol Oncol. 2006;103:535–40.

    Article  CAS  PubMed  Google Scholar 

  14. Weiderpass E, Adami HO, Baron JA, Magnusson C, Lindgren A, Persson I. Use of oral contraceptives and endometrial cancer risk (Sweden). Cancer Causes Control. 1999;10(4):277–84.

    Article  CAS  PubMed  Google Scholar 

  15. Benshushan A, Paltiel O, Rojansky N, Brzezinski A, Laufer N. IUD use and the risk of endometrial cancer. Eur J Obstet Gynecol Reprod Biol. 2002;105(2):166–9.

    Article  PubMed  Google Scholar 

  16. Beining RM, Dennis LK, Smith EM, Dokras A. Meta-analysis of intrauterine device use and risk of endometrial cancer. Ann Epidemiol. 2008;18:492–9.

    Article  PubMed  Google Scholar 

  17. Dumesic DA, Lobo RA. Cancer risk and PCOS. Steroids. 2013;78(8):782–5.

    Article  CAS  PubMed  Google Scholar 

  18. Trabert B, Wentzensen N, Yang HP, Sherman ME, Hollenbeck AR, Park Y, Brinton LA. Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk? Int J Cancer. 2013;132(2):417–26.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Schlesselman JJ. Risk of endometrial cancer in relation to use of combined oral contraceptives. A practitioner’s guide to meta-analysis. Hum Reprod. 1997;12:1851–63.

    Article  CAS  PubMed  Google Scholar 

  20. Strom BL, Schinnar R, Weber AL, Bunin G, Berlin JA, Baumgarten M, DeMichele A, Rubin SC, Berlin M, Troxel AB, Rebbeck TR. Case–control study of postmenopausal hormone replacement therapy and endometrial cancer. Am J Epidemiol. 2006;164(8):775–86.

    Article  PubMed  Google Scholar 

  21. Swerdlow AJ, Jones ME. British tamoxifen second cancer study group. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case–control study. J Natl Cancer Inst. 2005;97(5):375–84.

    Article  CAS  PubMed  Google Scholar 

  22. Lavie O, Barnett-Griness O, Narod SA, Rennert G. The risk of developing uterine sarcoma after tamoxifen use. Int J Gynecol Cancer. 2008;18(2):352–6.

    Article  CAS  PubMed  Google Scholar 

  23. Lacey Jr JV, Sherman ME, Rush BB, Ronnett BM, Ioffe OB, Duggan MA, et al. Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia. J Clin Oncol. 2010;28:788–92.

    Article  PubMed Central  PubMed  Google Scholar 

  24. Molina-Montes E, Pollán M, Payer T, Molina E, Dávila-Arias C, Sánchez MJ. Risk of second primary cancer among women with breast cancer: a population-based study in Granada (Spain). Gynecol Oncol. 2013;130(2):340–5.

    Article  PubMed  Google Scholar 

  25. Chang SC, Lacey Jr JV, Brinton LA, Hartge P, Adams K, Mouw T, Carroll L, Hollenbeck A, Schatzkin A, Leitzmann MF. Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers Prev. 2007;16(4):723–30.

    Article  CAS  PubMed  Google Scholar 

  26. Parslov M, Lidegaard O, Klintorp S, Pedersen B, Jønsson L, Eriksen PS, Ottesen B. Risk factors among young women with endometrial cancer: a Danish case–control study. Am J Obstet Gynecol. 2000;182:23–9.

    Article  CAS  PubMed  Google Scholar 

  27. Tornberg SA, Carstensen JM. Relationship between Quetelet’s index and cancer of breast and female genital tract in 47 000 women followed for 25 years. Br J Cancer. 1994;69:358–61.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. McCullough ML, Patel AV, Patel R, Rodriguez C, Feigelson HS, Bandera EV, Gansler T, Thun MJ, Calle EE. Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype. Cancer Epidemiol Biomarkers Prev. 2008;17(1):73–9.

    Article  CAS  PubMed  Google Scholar 

  29. Trentham-Dietz A, Nichols HB, Hampton JM, Newcomb PA. Weight change and risk of endometrial cancer. Int J Epidemiol. 2006;35(1):151–8.

    Article  CAS  PubMed  Google Scholar 

  30. Rogers J, Mitchell GW. The relation of adiposity to menstrual disturbances. N Engl J Med. 1952;247:53–5.

    Article  CAS  PubMed  Google Scholar 

  31. Key TJ, Pike MC. The dose-effect relationship between ‘unopposed’ oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer. 1988;57:205–12.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  32. Anderson DC. Sex hormone binding globulin. Clin Endocrinol. 1974;6:69–72.

    Article  Google Scholar 

  33. Moore SC, Gierach GL, Schatzkin A, Matthews CE. Physical activity, sedentary behaviours, and the prevention of endometrial cancer. Br J Cancer. 2010;103(7):933–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  34. Levi F, Franceschi S, Negri E, La Vecchia C. Dietary factors and the risk of endometrial cancer. Cancer. 1993;71:3575–81.

    Article  CAS  PubMed  Google Scholar 

  35. Shu XO, Zheng W, Potischman N, Brinton LA, Hatch MC, Gao YT, Fraumeni Jr JF. A population-based case–control study of dietary factors and endometrial cancer in Shanghai, People’s Republic of China. Am J Epidemiol. 1993;137:155–65.

    CAS  PubMed  Google Scholar 

  36. Littman AJ, Beresford SA, White E. The association of dietary fat and plant foods with endometrial cancer (United States). Cancer Causes Control. 2001;12(8):691–702.

    Article  CAS  PubMed  Google Scholar 

  37. Maatela J, Aromaa A, Salmi T, Pohja M, Vuento M, Grönroos M. The risk of endometrial cancer in diabetic and hypertensive patients: a nationwide record-linkage study in Finland. Ann Chir Gynaecol Suppl. 1994;208:20–4.

    CAS  PubMed  Google Scholar 

  38. Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, Nicotera T. Oxidative damage to DNA in diabetes mellitus. Lancet. 1996;347:444–5.

    Article  CAS  PubMed  Google Scholar 

  39. Sun Y. Free radicals, antioxidant enzymes and carcinogenesis. Free Radic Biol Med. 1990;8:583–99.

    Article  CAS  PubMed  Google Scholar 

  40. Zhang ZH, Su PY, Hao JH, Sun YH. The role of preexisting diabetes mellitus on incidence and mortality of endometrial cancer: a meta-analysis of prospective cohort studies. Int J Gynecol Cancer. 2013;23(2):294–303.

    Article  PubMed  Google Scholar 

  41. Friberg E, Orsini N, Mantzoros CS, Wolk A. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia. 2007;50:1365–74.

    Article  CAS  PubMed  Google Scholar 

  42. Friberg E, Mantzoros CS, Wolk A. Diabetes and risk of endometrial cancer: a population-based prospective cohort study. Cancer Epidemiol Biomarkers Prev. 2007;16:276–80.

    Article  PubMed  Google Scholar 

  43. Major FJ, Blessing JA, Silverberg SG, et al. Prognostic factors in early stage uterine sarcoma: a Gynecologic Oncology Group study. Cancer. 1993;71:1702–9.

    Article  CAS  PubMed  Google Scholar 

  44. Kobayashi H, Uekuri C, Akasaka J, Ito F, Shigemitsu A, Koike N, Shigetomi H. The biology of uterine sarcomas: a review and update. Mol Clin Oncol. 2013;1:599–609.

    PubMed Central  PubMed  Google Scholar 

  45. Zelmanowicz A, Hildesheim A, Sherman ME, Sturgeon SR, Kurman RJ, Barrett RJ, Berman ML, Mortel R, Twiggs LB, Wilbanks GD, Brinton LA. Evidence for a common etiology for endometrial carcinomas and malignant mixed Mullerian tumors. Gynecol Oncol. 1998;69:253–7.

    Article  CAS  PubMed  Google Scholar 

  46. Felix AS, Cook LS, Gaudet MM, Rohan TE, Schouten LJ, Setiawan VW, Wise LA, Anderson KE, Bernstein L, De Vivo I, Friedenreich CM, Gapstur SM, Goldbohm RA, Henderson B, Horn-Ross PL, Kolonel L, Lacey JV, Liang X, Lissowska J, Magliocco A, McCullough ML, Miller AB, Olson SH, Palmer JR, Park Y, Patel AV, Prescott J, Rastogi R, Robien K, Rosenberg L, Schairer C, Ou Shu X, van den Brandt PA, Virkus RA, Wentzensen N, Xiang YB, Xu WH, Yang HP, Brinton LA. The etiology of uterine sarcomas: a pooled analysis of the epidemiology of endometrial cancer consortium. Br J Cancer. 2013;108(3):727–34.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  47. National Cancer Institute Information. http://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0023668/. Accessed 2 Dec 2013.

  48. Jaakkola S, Lyytinen HK, Pukkala E, Ylikorkala O. Use of estradiol-progestin therapy associates with increased risk for uterine sarcomas. Gynecol Oncol. 2011;122(2):260–3.

    Article  CAS  PubMed  Google Scholar 

  49. Bergman L, Beelen ML, Gallee MP, Hollema H, Benraadt J, van Leeuwen FE. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive cancer centres’ ALERT group. Assessment of liver and endometrial cancer risk following tamoxifen. Lancet. 2000;356(9233):881–7.

    Article  CAS  PubMed  Google Scholar 

  50. Cohen I. Endometrial pathologies associated with postmenopausal tamoxifen treatment. Gynecol Oncol. 2004;94(2):256–66.

    Article  CAS  PubMed  Google Scholar 

  51. Wickerham DL, Fisher B, Wolmark N, Bryant J, Costantino J, Bernstein L, Runowicz CD. Association of tamoxifen and uterine sarcoma. J Clin Oncol. 2002;20(11):2758–60.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Preventive Oncology, Tata Memorial Hospital, Mumbai, India

    Gauravi Mishra MD, Sharmila Pimple & Surendra Shastri

Authors
  1. Gauravi Mishra MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sharmila Pimple
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Surendra Shastri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gauravi Mishra MD .

Editor information

Editors and Affiliations

  1. Obstetrics and Gynecology, University College of Medical Sciences, New Delhi, India

    Shalini Rajaram

  2. Surgical &Gynec Oncology, Lakeshore & Welcare Hospitals, Kochi, Kerala, India

    Chitrathara K

  3. Gynec Onclogy, Tata Memorial Hospital, Mumbai, India

    Amita Maheshwari

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer India

About this chapter

Cite this chapter

Mishra, G., Pimple, S., Shastri, S. (2015). Epidemiology of Endometrial Cancers and Uterine Sarcomas. In: Rajaram, S., K, C., Maheshwari, A. (eds) Uterine Cancer. Springer, New Delhi. https://doi.org/10.1007/978-81-322-1892-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-81-322-1892-0_1

  • Publisher Name: Springer, New Delhi

  • Print ISBN: 978-81-322-1891-3

  • Online ISBN: 978-81-322-1892-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation